Allstate (NYSE:ALL - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of $3.98 per share and revenue of $16.41 billion for the quarter.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. On average, analysts expect Allstate to post $19 EPS for the current fiscal year and $22 EPS for the next fiscal year.
Allstate Trading Up 0.7 %
Allstate stock traded up $1.42 during mid-day trading on Monday, hitting $194.33. The stock had a trading volume of 207,946 shares, compared to its average volume of 1,610,115. The stock has a market capitalization of $51.52 billion, a PE ratio of 11.45, a P/E/G ratio of 1.01 and a beta of 0.36. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. Allstate has a 12 month low of $156.66 and a 12 month high of $212.91. The stock has a 50-day simple moving average of $197.62 and a two-hundred day simple moving average of $194.69.
Allstate Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were paid a $1.00 dividend. The ex-dividend date was Monday, March 10th. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a yield of 2.06%. Allstate's dividend payout ratio (DPR) is presently 23.54%.
Allstate announced that its Board of Directors has approved a share repurchase plan on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the insurance provider to purchase up to 3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.
Insider Buying and Selling at Allstate
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.80% of the company's stock.
Hedge Funds Weigh In On Allstate
A hedge fund recently raised its stake in Allstate stock. Brighton Jones LLC increased its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 60.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,500 shares of the insurance provider's stock after acquiring an additional 2,443 shares during the period. Brighton Jones LLC's holdings in Allstate were worth $1,253,000 at the end of the most recent reporting period. Institutional investors own 76.47% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have commented on ALL shares. Barclays lowered their target price on shares of Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Evercore ISI upgraded shares of Allstate from an "in-line" rating to an "outperform" rating in a report on Wednesday, January 8th. Wells Fargo & Company upped their target price on Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a report on Tuesday, January 14th. Keefe, Bruyette & Woods cut their price target on shares of Allstate from $240.00 to $228.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Finally, Argus upgraded Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Allstate presently has an average rating of "Moderate Buy" and a consensus target price of $219.27.
Check Out Our Latest Research Report on Allstate
Allstate Company Profile
(
Get Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.